'); //-->

Globe 100 Home
  | Index of coverage |

Top Ten
1. Teradyne Inc.
2. Analog Devices Inc.
3. LTX Corp.
4. EMC Corp.
5. Helix Tech. Corp.
6. ACT Manufacturing
7. Millipore Corp.
8. Talbots Inc.
9. Cytyc Corp.
10. FleetBoston

Year's Best
Company of year
Highest Market Value
Fastest Growth
Biggest Stock Gain
Comeback of the Year
Highest Sales

Overall performance
  1. ACT Manuf.
  2. Provant Inc.
  3. Analog Devices
  4. Sapient Corp.
  5. Foilmark Inc.
Bulls and Bears
  1. J. Jill Group
  2. Inverness Medical
  3. Reebok Intl.
  4. Bostonfed Bancorp
  5. John Hancock
  1. Aztec Tech.
  2. Engage Inc.
  3. CMGI Inc.
  4. Telaxis Comm.
  5. NaviSite Inc.

* The Globe 100
* Market value 100
* Sales 100
Return on equity 100
Growth 50
* Highest leveraged
* Top employers
* Most productive
* Industry summary
* Biggest profits
* Biggest losses
* The Bulls
* The Bears
* Top profit margins
* Debt-free companies
* Street's darlings
* Street's wallflowers
* 2000 Mass. IPOs
* Recoveries
* Nose Dives
All the charts for
this year's Globe 100

   | 2000 Globe 100 |

Sections Boston Globe Online: Page One Nation | World Metro | Region Business Sports Living | Arts Editorials

Search the Globe:


The Boston Globe OnlineBoston.com Boston Globe Online / Business / 2001 Globe 100

Millipore chief William Zadel
Millipore Corp. chief executive C. William Zadel in one of the Bedford company's training labs. (Globe File Photo)

Moving up in the rankings


Top 10 Companies

1. Teradyne Inc.
2. Analog Devices Inc.
3. LTX Corp.
4. EMC Corp.
5. Helix Tech. Corp.
6. ACT Manufacturing
7. Millipore Corp.
8. Talbots Inc.
9. Cytyc Corp.
10. FleetBoston

Get the chart
The 2001 Globe 100
All the charts

illipore sells high-tech tools and services for two distinctly different business lines: biosciences and semiconductors.

In fact, the Bedford company's ''halves'' are so different there are plans to split it in two, as early as this summer.

A new biosciences company, to be called Mykrolis, will be spun off, with its own stock, as a way to eliminate the management and engineering conflicts between

the two halves and improve the potential for each, the company said.

But last year, in the midst of operating as one company, both of Millipore's units had good years, resulting in record profits of $119.2 million.

Millipore's 2000 profits were among the factors that nudged the company to seventh place on The Globe 100, up from ninth the previous year.

''Usually, one is up while the other is down, but they were both up last year,'' said Francis Lunger, who became president last month.

Sales to Asia Pacific were especially strong last year, the company said. Yet financial success did not eliminate the need for layoffs.

During the first quarter of this year, Millipore laid off 400 of its 5,200 employees worldwide, to prepare for the reorganization. A $31 million restructuring charge sharply reduced first-quarter profits.

Last year, Millipore's biosciences operation benefited from a boom in new-drug approvals by the Food and Drug Administration that boosted demand for its filtration and chromatography systems, which are used in drug research and production.

Demand, Lunger said, ''was much stronger than we anticipated, and it came sooner in the year than we anticipated.''

Demand for Millipore's microelectronics products - components used to control or purify liquids and gases during semiconductor production - was even stronger, pushing up revenue for that division by 70 percent last year.

Lunger is more cautious about this year, because the semiconductor boom has ended, and the entire industry faces a downturn of unknown duration.

''In many ways, it was a phenomenal year,'' he said, adding, ''There's been a pullback.''



Boston Globe Extranet
Extending our newspaper services to the web
© Copyright 2001 Globe Newspaper Company

Return to the home page
of The Globe Online

Click here for advertiser information